ARGX logo

argenx SE (ARGX) EBITDA

Annual EBITDA:

-$46.35M+$293.86M(+86.37%)
December 31, 2024

Summary

  • As of today, ARGX annual EBITDA is -$46.35 million, with the most recent change of +$293.86 million (+86.37%) on December 31, 2024.
  • During the last 3 years, ARGX annual EBITDA has risen by +$325.46 million (+87.53%).
  • ARGX annual EBITDA is now -520.22% below its all-time high of -$7.47 million, reached on December 31, 2011.

Performance

1-Year Change

+86.37%

3-Year Change

+87.53%

5-Year Change

+77.56%

15-Year Change

-50.39%

ARGX EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

31.9%
ARGX annual EBITDA is higher than 31.9% of companies in Healthcare sector

Range

All-Time High

-$7.47M
ARGX annual EBITDA is currently -520.22% below its historical high of -$7.47 million

3-Year Low

-$641.62M
ARGX annual EBITDA is currently +92.78% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ARGX previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

Feb 26, 2026
ARGX next annual earnings announcement is scheduled for Feb 26, 2026

OtherARGXincome statement metrics

Annual Revenue

$2.19B
ARGX annual revenue is $2.19 billion

Annual Net Income

$831.57M
ARGX annual net profit is $831.57 million

Annual EBIT

-$63.85M
ARGX annual earnings before interest & taxes is -$63.85 million

Annual EPS

$12.76
ARGX annual earnings per share is $12.76

Quarterly EBITDA:

$388.89M+$149.43M(+62.40%)
September 30, 2025

Summary

  • As of today, ARGX quarterly EBITDA is $388.89 million, with the most recent change of +$149.43 million (+62.40%) on September 30, 2025.
  • Over the past year, ARGX quarterly EBITDA has increased by +$334.12 million (+610.01%).
  • ARGX quarterly EBITDA is now at all-time high.

Performance

3-Month Change

+62.4%

1-Year Change

+610.01%

3-Year Change

-

5-Year Change

+275.25%

ARGX Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

94.42%
ARGX quarterly EBITDA is higher than 94.42% of companies in Healthcare sector

Range

All-Time High

$388.89M
ARGX quarterly EBITDA is currently at an all-time high

3-Year Low

-$169.63M
ARGX quarterly EBITDA is currently +329.26% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ARGX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 26, 2026
ARGX next earnings announcement is scheduled for Feb 26, 2026

OtherARGXincome statement metrics

Quarterly Revenue

$1.13B
ARGX quarterly revenue is $1.13 billion

Quarterly Net Income

$344.26M
ARGX quarterly net profit is $344.26 million

Quarterly EBIT

$387.05M
ARGX quarterly earnings before interest & taxes is $387.05 million

Quarterly EPS

$5.18
ARGX quarterly earnings per share is $5.18

TTM EBITDA:

$923.95M+$334.12M(+56.65%)
September 30, 2025

Summary

  • As of today, ARGX TTM EBITDA is $923.95 million, with the most recent change of +$334.12 million (+56.65%) on September 30, 2025.
  • Over the past year, ARGX TTM EBITDA has increased by +$869.17 million (+1586.86%).
  • ARGX TTM EBITDA is now at all-time high.

Performance

3-Month Change

+56.65%

1-Year Change

+1586.86%

3-Year Change

-

5-Year Change

+516.37%

ARGX TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Percentile

93.08%
ARGX TTM EBITDA is higher than 93.08% of companies in Healthcare sector

Range

All-Time High

$923.95M
ARGX TTM EBITDA is currently at an all-time high

3-Year Low

-$391.54M
ARGX TTM EBITDA is currently +335.98% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2025
ARGX previous earnings announcement was published on Sep 30, 2025

Next Quarterly Earnings Report Date

Feb 26, 2026
ARGX next earnings announcement is scheduled for Feb 26, 2026

OtherARGXincome statement metrics

TTM Revenue

$3.60B
ARGX TTM revenue is $3.60 billion

TTM Net Income

$1.53B
ARGX TTM net profit is $1.53 billion

TTM EBIT

$965.78M
ARGX TTM earnings before interest & taxes is $965.78 million

TTM EPS

$7.76
ARGX TTM earnings per share is $7.76

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$46.35M
ARGX annual EBITDA is -$46.35 million

Annual Net Income

$831.57M
ARGX annual net profit is $831.57 million

Annual Interest Expense

$0.00
ARGX annual interest expense is $0.00

Annual Income Tax

-$792.56M
ARGX annual income tax is -$792.56 million

Annual D&A

$17.50M
ARGX annual D&A is $17.50 million

ARGX EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year+86.4%+610.0%+1586.9%
3Y3 Years+87.5%--
5Y5 Years+77.6%+275.3%+516.4%

ARGX EBITDA Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Yearat high+92.8%at high+329.3%at high+336.0%
5Y5-Yearat high+92.8%at high+275.3%at high+336.0%
All-TimeAll-Time-520.2%+92.8%at high+275.3%at high+336.0%

ARGX EBITDA History

DateAnnualQuarterlyTTM
Sep 2025
-
$388.89M(+62.4%)
$923.95M(+56.6%)
Jun 2025
-
$239.46M(+36.0%)
$589.82M(+68.3%)
Mar 2025
-
$176.06M(+47.3%)
$350.36M(+101.0%)
Dec 2024
-$46.35M(+86.4%)
$119.53M(+118.2%)
$174.31M(+218.2%)
Sep 2024
-
$54.77M(+132.3%)
$54.77M(+114.0%)
Dec 2023
-$340.21M(+47.0%)
-
-
Dec 2022
-$641.62M(-72.6%)
-
-
Jun 2022
-
-$169.63M(+23.6%)
-$391.54M(-76.4%)
Mar 2022
-
-$221.91M
-$221.91M
Dec 2021
-$371.82M(+24.4%)
-
-
Dec 2020
-$491.51M(-137.9%)
-
-
Dec 2019
-$206.60M(-105.2%)
-
-
DateAnnualQuarterlyTTM
Dec 2018
-$100.69M(-226.7%)
-
-
Dec 2017
-$30.82M(-28.3%)
-
-
Dec 2016
-$24.03M(-17.1%)
-
-
Dec 2015
-$20.53M(-42.9%)
-
-
Dec 2014
-$14.37M(-24.6%)
-
-
Jun 2014
-
-$4.54M(-39.7%)
-$9.86M(-6.2%)
Mar 2014
-
-$3.25M(-65.3%)
-$9.28M(-10.6%)
Dec 2013
-$11.53M(+20.1%)
-$1.97M(-1860.0%)
-$8.39M(-30.6%)
Sep 2013
-
-$100.30K(+97.5%)
-$6.43M(-1.6%)
Jun 2013
-
-$3.97M(-68.0%)
-$6.33M(-168.0%)
Mar 2013
-
-$2.36M
-$2.36M
Dec 2012
-$14.43M(-93.1%)
-
-
Dec 2011
-$7.47M
-
-

FAQ

  • What is argenx SE annual EBITDA?
  • What is the all-time high annual EBITDA for argenx SE?
  • What is argenx SE annual EBITDA year-on-year change?
  • What is argenx SE quarterly EBITDA?
  • What is the all-time high quarterly EBITDA for argenx SE?
  • What is argenx SE quarterly EBITDA year-on-year change?
  • What is argenx SE TTM EBITDA?
  • What is the all-time high TTM EBITDA for argenx SE?
  • What is argenx SE TTM EBITDA year-on-year change?

What is argenx SE annual EBITDA?

The current annual EBITDA of ARGX is -$46.35M

What is the all-time high annual EBITDA for argenx SE?

argenx SE all-time high annual EBITDA is -$7.47M

What is argenx SE annual EBITDA year-on-year change?

Over the past year, ARGX annual EBITDA has changed by +$293.86M (+86.37%)

What is argenx SE quarterly EBITDA?

The current quarterly EBITDA of ARGX is $388.89M

What is the all-time high quarterly EBITDA for argenx SE?

argenx SE all-time high quarterly EBITDA is $388.89M

What is argenx SE quarterly EBITDA year-on-year change?

Over the past year, ARGX quarterly EBITDA has changed by +$334.12M (+610.01%)

What is argenx SE TTM EBITDA?

The current TTM EBITDA of ARGX is $923.95M

What is the all-time high TTM EBITDA for argenx SE?

argenx SE all-time high TTM EBITDA is $923.95M

What is argenx SE TTM EBITDA year-on-year change?

Over the past year, ARGX TTM EBITDA has changed by +$869.17M (+1586.86%)
On this page